Key highlights

  • Energy Technologies (ASX:EGY) reported September-quarter sales of AUD 1.270 million.
  • Net operating cash outflow fell to AUD 679,000.
  • Cogenic’s smart-glasses framework includes a USD 250,000 proof of concept.

Energy Technologies (ASX:EGY) rose 10.00% to AUD 0.022 during trading on 20 November 2026. Across the broader market, the S&P/ASX 200 was at 8,632.80 at 11:59 a.m. Sydney time. All 11 sectors were lower. The specialist industrial cable group reported its September-quarter results and a post-quarter optical technology agreement on 29 October 2026.

September sales and operating cash flow

On 29 October 2026, Energy Technologies reported sales of AUD 1.270 million for Q1 FY27, up from AUD 812,000 in the June quarter. Customer cash receipts increased to AUD 1.503 million from AUD 849,000. Net operating cash outflow was AUD 679,000, compared with AUD 1.357 million in the preceding quarter and AUD 721,000 in the September 2025 quarter.

Bambach Wires and Cables continued its restructuring as the group worked toward cash-flow break-even at the subsidiary. It installed cable-building software at its Rosedale factory. Management expects the system to improve operational processes. The quarter’s consolidated Operating Cash Flow remained negative despite higher cash receipts and a reduced outflow.

Cogenic sets terms for smart-glasses trial

Cogenic signed binding heads of agreement with SYNCH on 20 October, after the September quarter. The one-year framework allows the customer to place purchase orders of up to USD 10 million in aggregate following successful acceptance of a proof of concept. The initial program covers ten field-operational smart-glasses units and totals USD 250,000.

Under those terms, an initial USD 50,000 payment was due, with the USD 200,000 balance payable after acceptance, subject to agreed conditions. Subsequent orders are discretionary, with no minimum volume. In a separate quarterly development, Cogenic entered a master licence agreement with Amalgamated Vision to develop an optical platform using Cogenic’s laser scanning technology. That licence provides for no immediate revenue.

The group also reported board changes during the quarter. Kurt Hansen joined as a non-executive director with experience across technology, Cybersecurity and defence. Doron Eldar became an executive director. The Quarterly Report identified Bambach’s manufacture and sale of specialist cables and ancillary products as the group’s primary operating activity during the period.

Sector context

Industrials was down 1.75% during the session. The group’s Rosedale operation makes industrial cable products, while Cogenic’s agreements concern optical systems for field use and product development in US defence and aerospace markets. These activities were at distinct commercial stages during the period, ranging from ongoing factory operations to prototype development.

Risks investors are watching

The group continued to use operating cash in the September quarter, while Bambach was still working toward cash-flow break-even. Cogenic’s customer must accept the proof of concept under the agreed conditions before the balance becomes payable. The broader framework leaves follow-on orders to the customer’s discretion, and the USD 10 million ceiling covers potential orders under the existing agreement.

What to watch ahead

Cogenic’s immediate milestone under the SYNCH arrangement is delivery and acceptance of the ten-unit proof of concept. Further orders would follow at the customer’s discretion. For Bambach, the operational milestones are implementation of the new factory processes and progress toward the subsidiary’s cash-flow target, with future quarterly figures providing an update on collections and expenditure.

The next milestones

The quarter ended with higher sales and a smaller operating cash outflow. The post-quarter agreement sets out a staged commercial process in which prototype acceptance comes before any discretionary orders under the broader framework.